Concentrations of lead in the air remain substantial in developed and developing countries, largely the result of industrial emissions.
GSK to acquire Chimagen’s CMG1A46 for autoimmune treatment
The acquisition of CMG1A46 is a strategic move to address the diverse manifestations of lupus and the ongoing burden it places on patients. Credit: Indypendenz/Shutterstock.
October 30, 2024